pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Cleave Biosciences is a pioneer in the discovery and development of drugs that target protein homeostasis systems and have the potential to transform the treatment of people with difficult to treat solid tumors and hematologic malignancies.

LOCATION

  • Burlingame, CA, USA

    • THERAPEUTIC AREAS

  • Oncology

    • WEBSITE

    https://cleavebio.com

    CAREER WEBSITE

    https://www.cleavebio.com/careers/

    SOCIAL MEDIA

    INVESTORS

    5am-ventures arcus-ventures astellas-venture-management clarius-ventures nea nextech-invest orbimed osage-university-partners usvp

    PRESS RELEASES


    Jan 6, 2017

    Cleave Biosciences Promotes Kanya Rajangam to Chief Medical Officer


    Aug 8, 2016

    Cleave Biosciences Raises $37 Million Series B Financing


    Jun 1, 2016

    Cleave Biosciences Names Tim Smith as Chief Business Officer


    Jul 30, 2015

    Cleave Biosciences Granted Key U.S. Patent Covering CB-5083


    Jul 13, 2015

    Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma


    For More Press Releases
    Google Analytics Alternative